Gwo Xi Stem Cell Applied Technology Co. , Ltd (6704.TWO)
TWD 21.65
(-2.04%)
TWD 21.65
(-2.04%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -16.59 Million TWD | 66.06% |
| 2022 | -49.93 Million TWD | 20.77% |
| 2021 | -60.52 Million TWD | -49.39% |
| 2020 | -44.17 Million TWD | 37.03% |
| 2019 | -66.46 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -9.16 Million TWD | 0.0% |
| 2024 Q1 | -9.16 Million TWD | 29.53% |
| 2023 Q2 | -7.64 Million TWD | 0.0% |
| 2023 Q4 | -13 Million TWD | 0.0% |
| 2023 Q1 | -7.64 Million TWD | 43.58% |
| 2023 FY | - TWD | 66.06% |
| 2023 Q3 | -13 Million TWD | -70.26% |
| 2022 Q3 | -13.54 Million TWD | 0.0% |
| 2022 FY | - TWD | 20.77% |
| 2022 Q4 | -13.54 Million TWD | 0.0% |
| 2021 FY | - TWD | -49.39% |
| 2020 FY | - TWD | 37.03% |
| 2019 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 104.217% |
| Level Biotechnology Inc. | 98.7 Million TWD | 116.816% |
| Sagittarius Life Science Corp | -44.73 Million TWD | 62.9% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | 76.984% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 88.449% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 83.981% |
| Visgeneer Inc. | 973 Thousand TWD | 1805.858% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 101.772% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 116.625% |
| Neith Corporation | -33.61 Million TWD | 50.616% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -855.556% |
| Enimmune corporation | -228.96 Million TWD | 92.751% |
| TaiRx, Inc. | -208.64 Million TWD | 92.045% |
| EirGenix Inc. | -664.4 Million TWD | 97.502% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 122.459% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 124.005% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 79.271% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 85.325% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 147.643% |
| Lukas Biomedical Inc. | -26.3 Million TWD | 36.89% |
| RBC Bioscience Corporation | 36.54 Million TWD | 145.415% |
| BiOptic Inc. | 65.03 Million TWD | 125.52% |
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | 64.108% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | 49.712% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | 69.775% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 103.828% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 95.111% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 98.325% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | 73.375% |
| TaiMed Biologics Inc. | -25.23 Million TWD | 34.221% |
| GlycoNex Incorporation | -126.82 Million TWD | 86.913% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 176.103% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | 6.364% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 98.451% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 97.568% |
| VBI | -6.97 Million TWD | -138.067% |
| CHO Pharma, Inc. | -277.73 Million TWD | 94.024% |
| NaviFUS Corp. | -55.79 Million TWD | 70.252% |
| Sinew Pharma Inc. | -163.63 Million TWD | 89.856% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | 73.011% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 108.627% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 92.678% |
| AP Biosciences Inc | -325.51 Million TWD | 94.901% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 98.411% |
| 3D Global Biotech Inc. | -35.84 Million TWD | 53.696% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 156.979% |
| Intech Biopharm Corporation | -219.58 Million TWD | 92.441% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 97.538% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | 63.075% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 89.682% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 102.532% |
| TCI GENE Inc. | 25.98 Million TWD | 163.885% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 84.998% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 94.151% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 88.629% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 219.841% |
| PharmaEngine, Inc. | 347.3 Million TWD | 104.779% |
| Savior Lifetec Corporation | 219.6 Million TWD | 107.558% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 109.637% |
| OBI Pharma, Inc. | -855.08 Million TWD | 98.059% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | 82.068% |
| Acepodia, Inc. | -764.51 Million TWD | 97.829% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 96.392% |